应用超音速剪切波成像验证代偿期进展性慢性肝病的诊断阈值
本研究回顾性纳入1180例慢性肝病高危患者,以食管静脉曲张和/或肝活检严重纤维化或肝硬化为代偿期进展性慢性肝病(cACLD)参考标准,验证放射科医师协会超声分会(SRU)推荐的ARFI技术阈值。测试集中SRU阈值<9 kPa排除cACLD的敏感度为81%、>13 kPa诊断cACLD的特异度为92%;ROC分析得出的最优阈值为<7 kPa和>12 kPa,排除敏感度91%、诊断特异度91%,验证集中分别为91%和92%,作者认为<7 kPa和>12 kPa双阈值优于SRU指南。
要点
- SRU阈值<9 kPa排除cACLD敏感度81%,>13 kPa诊断特异度92%,诊断性能欠佳。
- 超音速剪切波成像最优阈值为<7 kPa排除、>12 kPa诊断cACLD,敏感度和特异度均约91%。
- 验证集中最优阈值排除敏感度91%、诊断特异度92%,与测试集结果一致。
核心结论
- 与SRU指南相比,<7 kPa和>12 kPa的双肝硬度阈值对诊断cACLD更优。
研究设计与样本
- 回顾性单中心研究,纳入2018年1月至2021年12月间接受肝硬度测量及内镜或肝活检的高危慢性肝病患者1180例,随机分为测试集(n=786)和验证集(n=394)。
诊断标准与关键数值
- cACLD定义为内镜下静脉曲张和/或肝活检严重纤维化或肝硬化;测试集SRU阈值<9 kPa排除cACLD敏感度81%(303/374,95%CI:77,85),>13 kPa诊断cACLD特异度92%(380/412,95%CI:89,94);最优阈值<7 kPa排除敏感度91%(340/374,95%CI:88,93),>12 kPa诊断特异度91%(373/412,95%CI:87,93);验证集最优阈值排除敏感度91%(155/170,95%CI:86,95),诊断特异度92%(206/224,95%CI:88,95)。
临床应用与阅片要点
- 对慢性肝病高危患者行超音速剪切波成像时,可考虑采用<7 kPa和>12 kPa的双阈值分别排除和诊断cACLD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The Society of Radiologists in Ultrasound (SRU) has proposed thresholds for acoustic radiation force impulse techniques to diagnose compensated advanced chronic liver disease (cACLD). However, the diagnostic performance of these thresholds has not been extensively validated. Purpose To validate the SRU thresholds in patients with chronic liver disease who underwent supersonic shear imaging and, if suboptimal diagnostic performance is observed, to identify optimal values for diagnosing cACLD. Materials and Methods This retrospective single-center study included high-risk patients with chronic liver disease who had liver stiffness (LS) measurements and had undergone endoscopy or liver biopsy between January 2018 and December 2021. Patients were randomly allocated to test and validation sets. cACLD was defined as varices at endoscopy and/or severe fibrosis or cirrhosis at liver biopsy. The diagnostic performance of the SRU guidelines was evaluated, and optimal threshold values were identified using receiver operating characteristic (ROC) curve analysis. Results A total of 1180 patients (median age, 57 years [IQR, 50-64 years]; 761 men), of whom 544 (46%) had cACLD, were included. With the SRU recommended thresholds of less than 9 kPa and greater than 13 kPa in the test set (n = 786), the sensitivity and specificity for ruling out and ruling in cACLD were 81% (303 of 374 patients; 95% CI: 77, 85) and 92% (380 of 412 patients; 95% CI: 89, 94), respectively. In ROC curve analysis, the identified optimal threshold values were less than 7 kPa and greater than 12 kPa, showing 91% sensitivity (340 of 374 patients; 95% CI: 88, 93) for ruling out cACLD and 91% specificity (373 of 412 patients; 95% CI: 87, 93) for ruling in cACLD, respectively. In the validation set (n = 394), the optimal thresholds showed 91% sensitivity (155 of 170 patients; 95% CI: 86, 95) and 92% specificity (206 of 224 patients; 95% CI: 88, 95). Conclusion Compared with the SRU guidelines, the dual LS threshold values of less than 7 kPa and greater than 12 kPa were better for diagnosing cACLD. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Barr in this issue.
引用
- Lee Y, Kim NH, Kang JH, et al. Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging. Radiology. 2024. PMID: 38591973. doi:10.1148/radiol.232188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。